Andrew Fromkin
Description Andrew J. Fromkin joined Clinical Data on October 12, 2005, and was elected President, Chief Executive Officer, and a director of the Company on May 12, 2006. Mr. Fromkin has over twenty years of senior leadership experience in the healthcare industry with an emphasis on healthcare information and services, pharmaceutical services and biotechnology. Prior to Clinical Data, Mr. Fromkin held senior management roles at leading and emerging healthcare companies. Most recently he was President and Chief Executive Officer of DoctorQuality, Inc., a leading provider of patient safety and condition management products that was acquired by Quantros, Inc., and served as President, Chief Executive Officer, and a director of Endo Surgical Devices, Inc., an early stage surgical device developer. Mr. Fromkin spent most of the 1990?s in two leadership roles with the industry?s leading prescription benefit management company (PBM), Medco which became Merck-Medco Managed Care, LLC, a wholly owned subsidiary of Merck & Co., Inc. These leadership roles included Vice President, Business Development (Corporate Development from 1995-2000) and prior to that, Vice President, Sales to Major Health Insurers, Employers and Government Accounts. Mr. Fromkin began his career at Health Information Technologies, a leader in the then emerging field of electronic data interchange. The Board concluded that Mr. Fromkin should continue to serve as a director based upon his role with the Company, his prior experience in senior leadership roles in the health care industry, and his ongoing experience and accomplishments as President and Chief Executive Officer of the Company. To view the detailed information, you need to SUBSCRIBE with us. |
 |